Bacillus cereus DNA topoisomerase I and IIIα: purification, characterization and complementation of Escherichia coli TopoIII activity by Li, Zhiyu et al.
Bacillus cereus DNA topoisomerase I and IIIa:
purification, characterization and complementation
of Escherichia coli TopoIII activity
Zhiyu Li, Hiroshi Hiasa
1 and Russell DiGate*
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MA, USA and
1Department of Pharmacology, University of Minnesota Medical School, MN, USA
Received June 1, 2005; Revised and Accepted September 1, 2005
ABSTRACT
The Bacillus cereus genome possesses three type
IA topoisomerase genes. These genes, encoding
DNA topoisomerase I and IIIa (bcTopo I, bcTopo
IIIa), have been cloned into T7 RNA polymerase-
regulated plasmid expression vectors and the
enzymes have been overexpressed, purified and
characterized. The proteins exhibit similar biochemi-
cal activity to their Escherichia coli counterparts,
DNA topoisomerase I and III (ecTopo I, ecTopo III).
bcTopo I is capable of efficiently relaxing negatively
supercoiledDNAinthepresenceofMg
21butdoesnot
possess an efficient DNA decatenation activity.
bcTopoIIIaisanactivetopoisomerasethatiscapable
of relaxing supercoiled DNA at a broad range of
Mg
21 concentrations; however, its DNA relaxation
activity is not as efficient as that of bcTopo I. In addi-
tion, bcTopo III is a potent DNA decatenase that
resolves oriC-based plasmid replication intermedi-
ates in vitro. Interestingly, bcTopo I and bcTopo IIIa
are both able to compensate for the loss of ecTopo III
in E.coli cells that lack ecTopo I. In contrast, ecTopo I
cannot substitute for ecTopo III under these
conditions.
INTRODUCTION
DNA topoisomerases resolve entangled DNA intermediates
by transiently cleaving one or two DNA strands and passing
another intact strand(s) through the nick. Subsequently, the
enzymes rejoin the DNA break and ﬁnish one round of this
catalytic reaction (1,2). Based on their catalytic mechanism,
topoisomerases have been categorized into four subfamilies,
type IA and IB, and type IIA and IIB. Type IA topoisomerases
transiently break single-stranded DNA and form a covalent
tyrosyl-DNA phosphodiester bond through a 50 phosphate.
They are highly conserved from bacteria to humans. In
most cells, two type IA topoisomerases are present and at
least one is needed for viability (3). Escherichia coli possesses
two type IA topoisomerases, ecTopo I (4) and ecTopo III (5).
Among all characterized type IA topoisomerases, ecTopo
I-like enzymes are capable of relaxing negatively supercoiled
DNA efﬁciently. Therefore, ecTopo I in conjunction with
DNA gyrase (a type IIA enzyme) functions in the regulation
of chromosomal superhelicity (6,7). Although ecTopo III
relaxes negatively supercoiled DNA, it is dramatically more
efﬁcient inthe resolution ofinterlinked DNA dimers,a process
of intermolecular strand passage (8,9). In vivo, topB (gene
encoding ecTopo III) null strains exhibit heightened frequen-
cies of illegitimate recombination (10).
Drosophila, mouse and human also have two type IA
topoisomerases, topoisomerase 3a and 3b (TOP3a, TOP3b)
(11–13). The deletion of the gene encoding mouse TOP3a
results in an embryonic lethal phenotype (14), whereas inac-
tivation of TOPb leads to infertility and a shortened life span
(15,16). Saccharomyces cerevisiae and Saccharomyces pombe
only encode a single type IA topoisomerase, Topoisomerase 3
(TOP3). A TOP3 mutation in S.cerevisiae causes slow growth,
sporulation defects and severe defects in DNA repair and
recombination (17). Interestingly, TOP3 in S.pombe is essen-
tial for survival (18).
A BlastP (19) search of ecTopo III homologs in the NCBI
microbialgenomic database revealsthatmanybacteria contain
two or more chromosomally encoded type IA topoisomerases.
Among the Bacillus, Bacillus anthracis (20), Bacillus cereus
(21) and Bacillus thuringiensis have three chromosomal
copies of type IA topoisomerases. Two promiscuous plasmids,
pXO1 and pXO2, harbored by B.anthracis encode virulence
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doi:10.1093/nar/gki846factors that cause anthrax (22). These plasmids can be mobi-
lized and it has been reported that B.cereus, containing pXO1
and pXO2-like plasmids, is able to cause an illness resembling
inhalation anthrax in mouse (23). Interestingly, pXO1 and
pXO2 appear to encode two additional type IA topoiso-
merases. Therefore, ﬁve type IA topoisomerases may be
present in these bacteria. In addition, Gram-positive bacteria
that are of clinical importance, such as Clostoridium
pertringens (24), Clostoridium tetani (25), Enterococcus
faecalis (26) and Staphylococcus epidermidis (27), also pos-
sessmultiplechromosomally-encodedtypeIAtopoisomerases.
Similar to pXO1 and pXO2 of B.anthracis, many broad-
host-range promiscuous plasmids also encode type IA topoi-
somerases. For example, the traE gene of the IncPa plasmid
RP4 encodes a type IA topoisomerase (28). Since these plas-
mids are also able to mobilize among cells, many bacteria may
possess three or more type IA topoisomerases. The biological
relevance of multiple copies of type IA topoisomerases,
however, remains unclear.
B.cereus is a soil-dwelling opportunistic pathogen that
causes infections such as endophthalmitis, bacteremia, sep-
ticemia, endocarditis, salpingitis, cutaneous infections, pneu-
monia and meningitis (23). Since B.cereus and B.anthracis are
closely related and share high degree of genomic sequence
identity, the study of the DNA recombination and repair in
B.cereus may provide valuable information in the understand-
ing of the process of DNA metabolism in B.anthracis and help
to identify novel targets for antibiotic design and screening. In
this study, two of B.cereus type IA topoisomerases, annotated
ecTopo I and ecTopo IIIa, have been cloned, expressed, puri-
ﬁed and characterized. Although these two enzymes exhibit
distinctly different biochemical activity, they both are able to
substitute for the loss of ecTopo III in vivo.
MATERIALS AND METHODS
DNA and nucleotides
FX174 replicative form I DNA (covalently closed, negatively
supercoiled double stranded DNA) was purchased from
Invitrogen. DNA oligonucleotides were prepared by the
University of Maryland Biopolymer Laboratory. Radiolabeled
nucleoside triphosphate was purchased from Amersham Corp.
Enzymes and reagents
Acrylamide, restriction enzymes and agarose were obtained
from Invitrogen. DE52 and P-11 cellulose were purchased
from Whatman. Trypsin inhibitor-agarose and single-
stranded DNA-cellulose were from Sigma. Sephacryl S-200
was from Pharmacia Biotech Inc. The B.cereus ATCC 14579
genomic DNA was purchased from ATCC. Advantage2
polymerase was purchased from Clontech.
Protein determination
Protein concentration was determined by the method of
Bradford using a BioRad protein assay kit.
Radiolabeling of oligonucleotides
Oligonucleotides were 50 end-labeled using bacteriophage T4
polynucleotide kinase (New England Biolabs) and [g-
32P]ATP
following the manufacturer’s recommendations. The labeled
oligonucleotides were fractionated on a polyacrylamide gel.
The region containing the labeled oligonucleotide was
excised, and the DNA was isolated by direct elution of the
fragment into 10 mM Tris–HCl (pH 7.5 at 22 C) and 1 mM
EDTA. The radiolabeled oligonucleotides were diluted to a
speciﬁc activity of 5000 c.p.m./pmol by the addition of excess
unlabeled oligonucleotide.
ConstructionofthebcTopoIIIaandbcTopoIexpression
vectors
The gene encoding the bcTopo IIIa protein was ampliﬁed by
the PCR using the following primer sequences: 50-GGAGC-
CATATGAAATTAATTATTGCCGAG-30 (N-terminal) and
50-ATCCCGCTCGAGTTAATTCTCAAATACAAAATTAA-
TCG-30 (C-terminal). The ampliﬁed product contained a NdeI
restriction site (boldface) encompassing the initiation codon of
bcTopo IIIa gene (topBa), and a XhoI site (boldface) after the
termination codon of the topBa open reading frame (ORF).
The ampliﬁed product was treated with NdeI and XhoI and
ligated with NdeI/XhoI-digested plasmid vector pET21b
(pTopo3a). The gene encoding the bcTopo I protein was
also ampliﬁed by the PCR using the following primer
sequences: 50-CCGTCTAGAAATAATTTTGTTTAACTT-
TAAGAAGGAGAGGCTAGCATGTCAGATTACCTCGTA-
ATCGTGG-30 (N-terminal) and 50-ATCCCGCTCGAGTCA-
CATTTGTTGTTCTTCTTC-30 (C-terminal). The ampliﬁed
product contained an XbaI restriction site (boldface) and ribo-
some binding site (underlined) preceding the initiation codon
(italicized) of the bcTopo I gene (topA), and an XhoI site
(boldface) after the termination codon of the topA ORF.
The ampliﬁed product was treated with XbaI and XhoI and
ligated with XbaI/XhoI-digested plasmid vector pET21b
(pTopo1). The expression vectors were sequenced to ensure
that no mutations occurred during the PCR ampliﬁcation
process.
Sequencing errors were found in the published sequence of
bcTopo I gene. Based on the published sequence, the ORF
(3811119–3809131 of complete genome) that encodes
bcTopo I lacks the ﬁrst 30 amino acids that are present in
other homologs. The region ﬂanking the putative start
codon of 3811119 has been ampliﬁed by PCR using Pfu
DNA polymerase. Sequencing of this fragment reveals that
an extra C is present at position 38111144 of published
sequence.Thisleadstoa+1frameshiftandcauses apremature
stop within an ORF that starts at position of 3811210 (ORF
3811210–3811031). Without this base, the correct ORF
(3811210–3809131) encodes a full length bcTopo I that is
almost identical to the homolog from B.anthracis. In addition,
at several other positions, the DNA sequence from the PCR
ampliﬁed gene was not consistent with the published
sequence; however, the derived amino acids from ampliﬁed
gene at these sites were identical to that of bcTopo I homologs
from B.anthracis and B.thuringiensis. Since these ambiguous
sequences may be result of sequencing errors, these sites were
not altered. These sites are (the published sequences are shown
in underline) 11 Pro (CCT)/Arg (CGT), 125 Pro (CCT)/Leu
(CTT), 187 Pro (CCT)/Leu (CTT), 319 Thr (ACT)/Ile (ATT),
321 Ala (GCG)/Val (GTC), 322 Tyr (TAT)/Asp (GAT) and
632 Ser (AGT)/Ile (ATT).
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The induction of the bcTopo IIIa polypeptide was initiated by
infection of the expression strain, harboring the pTopo3a
plasmid DNA, with bacteriophage lCE6. To prevent any con-
tamination of the bcTopo IIIa protein with endogenous
ecTopo III, it was puriﬁed from E.coli strain BL21 in
which the gene encoding ecTopo III (topB) had been dis-
rupted. The pellets of induced BL21 cells (1L) were resus-
pended in 15 ml of BugBuster buffer (Novagen) followed by
centrifugation (30 min, 40 000 g). The pellets were resus-
pended with 15 ml buffer B (20 mM Tris–HCl, pH 8.0;
1 mM DTT; 1 mM EDTA, pH 8.0; 10% glycerol; 1 M NaCl)
followed by centrifugation (30 min, 40 000 g). The super-
natants containing bcTopo IIIa were then dialyzed in
1.5 l buffer A (20 mM Tris–HCl, pH 8.0; 1 mM DTT;
1 mM EDTA, pH 8.0; 10% glycerol) overnight. The desalted
crude protein extract was loaded onto 20 ml DE52 cellulose
column (2.5 · 10 cm) equilibrated with buffer A. The proteins
that bound to DE52 cellulose were step-eluted with 40 ml of
buffer A containing 50, 100, 150 and 200 mM NaCl. The
150 and 200 mM NaCl pools were combined and dialyzed
against 1.5 l buffer A overnight. The proteins were further
puriﬁed by single-stranded DNA-cellulose and Sephacryl
S-200 chromatography as described previously (29). Proteins
bound to single-stranded DNA cellulose were eluted using
buffer A containing 1 M NaCl. The same protocol was
used to overexpress and purify bcTopo I.
Superhelical DNA relaxation assays
Superhelical DNA relaxation reaction mixtures (25 ml) con-
tained 40 mM Tris–HCl buffer (pH 8.0 at 22 C), 1 mM mag-
nesium acetate (pH 7.0), 0.1 mg/ml BSA, 40% (v/v) glycerol,
200 ng of FX174 replicative form I DNA (Invitrogen) and the
indicated amount of topoisomerase. Reactions were incubated
at 52 C for 10 min for ecTopo III and bcTopo IIIa and 37 C
for 30 min for ecTopo I and bcTopo I. The reaction products
were separated on an agarose gel and visualized by staining
with ethidium bromide as described previously (28).
oriC DNA replication assay
The replication of oriC-containing DNA in vitro was per-
formed as described previously (8). The replication products
were separated by agarose gel electrophoresis. Replication
products were visualized and the percentage of replication
products existing as form II (nicked or gapped circular) mole-
cules was quantiﬁed using a Fuji BAS 1000 phosphoimager.
Topoisomerase-mediated single-stranded DNA
binding assay
Reaction mixtures (10 ml) contained 40 mM Tris–HCl buffer
(pH 8.0 at 22 C), 0.1 mg/ml BSA, 1 mM magnesium acetate
(pH 7.0) and 5 pmol of a radiolabeled 28-base oligonucleotide.
The oligonucleotide was 50-TTTTCATCCCGAAGTTGCGG-
CTCATTCT-30. The reactions were incubated for 5 min at
37 C, and were stopped by the addition of 10 ml of 20%
glycerol and 40 mM EDTA. The reaction products (10 ml)
were separated by electrophoresis on a 0.5· TBE polyacry-
lamide gel (19:1, 12%). The gels were then dried and
autoradiographed.
Topoisomerase-induced DNA cleavage assay
Reaction mixtures (10 ml) contained 40 mM Tris–HCl buffer
(pH 8.0 at 22 C), 0.1 mg/ml BSA, 1 mM magnesium acetate
(pH 7.0) and 5 pmol of a radiolabeled 28-base oligonucleotide.
The oligonucleotide was as described above. Reactions
containing the indicated amounts of ecTopo I, ecTopo III,
bcTopo I and bcTopo IIIa were incubated for 3 min at
37 C, and were stopped by the addition of SDS to 2%. The
reactions were adjusted to 45% formamide, 10 mM EDTA,
0.025% bromophenol blue and 0.025% xylene cyanol, and
heat-denatured for 5 min at 90 C. The reaction products
were separated by electrophoresis on a 15% 1· TBE poly-
acrylamide gel (19:1) containing 50% (w/v) urea. The gels
were then dried and autoradiographed.
Bacteriophage P1 transduction
Bacteriophage P1lysateswere prepared fromE.colistrainK38
topB:kan
r. This strain contains a topB gene disruption where
a kanamycin resistance cassette has been inserted into an
EcoRV site within the topB gene. E.coli strain DM750, har-
boring the appropriate plasmid DNA, was grown overnight in
Luria–Bertani (LB) medium (5 ml) containing 200 mg/ml
ampicillin. The cells were harvested and resuspended in
5 ml of sterile 0.1 M magnesium sulfate and 5 mM calcium
chloride. The resuspended cells were then incubated for
20 min at 37 C with gentle agitation. The cells (0.1 ml)
were mixed with 0.1 ml of the P1 lysate and allowed to
stand for 20 min at 37 C. Sodium citrate (0.2 ml of a 1 M
solution) was then added to the mixture, and 0.2 ml of the
mixture was distributed onto LB agar plates containing
50 mg/ml kanamycin and 100 mg/ml ampicillin. The plates
were incubated at 37 C, and the number of kanamycin/
ampicillin-resistant colonies was recorded after 18 h. The
mixture was also plated on agar medium containing only
ampicillin to determine the total number of recipient cells.
RESULTS
B.cereus encodes both E.coli Topo I and Topo III
homologs
A sequence comparison of ecTopo III using BlastP against the
B.cereus ATCC 14579 complete genomic sequence revealed
that this organism potentially contains three chromosomally
encoded type IA topoisomerases. Based on a homology
comparison and biochemical properties (this study), these
proteins have been annotated as topoisomerase I (bcTopo I,
gi:30021912),topoisomeraseIIIa(bcTopoIIIa,gi:30019974)
and topoisomerase IIIb (bcTopo IIIb, gi: 30018925), respec-
tively. bcTopo I is composed of 692 amino acids with a
molecular weight of 79.2 kDa and a predicated PI of 8.2
(the bcTopo I derived from the published genomic sequence
of B.cereus ATCC 14579 lacks the ﬁrst N-terminal 30 amino
acids owing to sequencing error as described in Materials and
Methods). bcTopo I exhibits 36% identity and 50% similarity
with ecTopo I. Similar to ecTopo I (30), it possesses three
tetracysteine zinc ﬁnger motifs; however, the C-terminal
region of ecTopo I (amino acid 743–865) has an additional
123 amino acids that are not present in bcTopo I. In addition,
a fragment that ranges from residue 41 to 69 in ecTopo I,
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tively charged residues, is also missing in bcTopo I. A further
sequence alignment indicates that this region is absent in many
ecTopo I-like enzymes. Interestingly, this region appears to be
disordered in the X-ray crystal structure of ecTopo I (31).
bcTopo IIIa is composed of 714 amino acids with a molecu-
lar weight of 81.5 kDa and a predicated PI of 9.4. Among the
ﬁrst 600 amino acids, ecTopo III and bcTopo IIIa exhibit 32%
identity and 55% similarity. Interestingly, unlike ecTopo III,
bcTopo IIIa possesses a highly charged C-terminal region
with a putative Zinc ﬁnger motif (Figure 1) that includes 24
positively charged and 16 negatively charged residues among
the last 114 C-terminal amino acids. Besides bcTopo I and
bcTopo IIIa, another type IA topoisomerase encoded by the
B.cereus genome is annotated bcTopo IIIb. Although bcTopo
IIIb shares 35% sequence identity and 55% sequence similar-
ity with ecTopo III, it is more similar to Bacillus subtilis
iopoisomerase III (64% sequence identity and 80% sequence
similarity) based on sequence alignment (Z. Li and R. DiGate,
manuscript submitted).
bcTopo I and bcTopo IIIa exhibit different biochemical
properties
In order to characterize the biochemical activities of bcTopo I
and bcTopo IIIa, the genes encoding these enzymes have been
cloned into the T7 RNA polymerase-based expression vector
pET21b as described in Materials and Methods. E.coli BL21
(topB)cellsharboringthe appropriateexpression plasmidwere
induced by lCE6 phage. The bcTopo I and IIIa were puriﬁed
to apparent homogeneity following a modiﬁed topoisomerase
puriﬁcation protocol (Materials and Methods) and their purity
was conﬁrmed by SDS–PAGE (Figure 2). Although these
proteins are all positively charged at pH 8.0 based on their
predicted PI, they bound to DE52 anion exchange cellulose
tightly and were eluted only in the presence of 150 mM NaCl.
Since both proteins possess efﬁcient single-stranded DNA
binding activities, they may bind to DE52 cellulose through
their interaction with contaminating nucleic acid or they
may also bind to the resin through locally negatively charged
regions within the enzyme itself.
TheDNArelaxationactivityofhighlypuriﬁedbcTopoIand
bcTopo IIIa have been assessed (Figure 3). Although both
enzymes exhibit relaxation activity, their mechanism appears
to be slightly different. bcTopo I relaxes supercoiled DNA
efﬁciently generating a processive pattern of topoisomers
(Figure 3A). Fully relaxed DNA species appear even at a
low protein concentration (2.2 nM,  1:1 enzyme to DNA
substrate). In addition, it is also able to convert the supercoiled
DNA substrate to almost fully relaxed form at higher concen-
trations. In contrast, bcTopo IIIa partially relaxes supercoiled
DNA in a much less processive manner (Figure 3B), although
it eventually converts supercoiled DNA to topoisomers that
are close to fully relaxed. Slightly higher concentrations of
bcTopo I and bcTopo IIIa in the reactions result in the
decrease of relaxation activity (data not shown). This may
be due to the result of protein aggregation.
The pH, Mg
2+ and temperature characteristics of bcTopo I
and IIIa have been determined based on a topoisomerase-
mediated supercoiled DNA relaxation assay (Figure 4).
bcTopo I exhibits consistent DNA relaxation activity within
a pH range from 6.5 to 10.4 (Figure 4A), whereas, bcTopo
IIIa-catalyzed DNA relaxation activity remains consistent
from a pH ranging from pH 8.0 to 9.8 (Figure 4B). Interest-
ingly, the DNA relaxation activity of bcTopo IIIa is slightly
inhibited at pH 7.5 and 10.4. Similar to ecTopo I (32), high
concentrations of Mg
2+ stimulate the DNA relaxation activity
of bcTopo I (Figure 4C). Although the enzyme is able to relax
DNA at 0.1 mM of Mg
2+, it displays a distributive pattern
rather than the processive pattern that appears at high con-
centrations of Mg
2+. The optimal concentration of Mg
2+ is
2.5 mM, higher concentrations of Mg
2+ (up to 20 mM) slightly
inhibit the DNA relaxation activity of bcTopo I. Unlike
ecTopo III, whose DNA relaxation activity is inhibited by
high concentrations of Mg
2+ (>2m M ) ,bcTopo IIIa is capable
of relaxing supercoiled DNA at a broad range of Mg
2+ con-
centrations (Figure 4D).bcTopoIIIaalso converts supercoiled
DNA molecules into partially relaxed topoisomers that are
close to that of the original supercoiled forms without addition
ofMg
2+(Figure4D,lane 2).This may be due toa trace amount
of Mg
2+ that remains during the protein puriﬁcation process
since the enzyme completely looses its relaxation activity in
the presence of 1 mM EDTA. The optimal Mg
2+ concentration
Figure 1. The putative zinc-finger motif of the C-terminal region of bcTopo IIIa. The charged residues (24 positively charged residues and 16 negatively charged
residues) are in boldface, the conserved cysteine residues that form a putative zinc-finger motif are shadowed in gray.
Figure 2. SDS–PAGE of purified bcTopo I and bcTopo IIIa. Lane 1, protein
massmarkers;lane2,bcTopoI;lane3,bcTopoIIIa.Purifiedenzymes(1.0mg)
were electrophoresed through a 10% polyacrylamide gel in the presence of
0.1% SDS. The protein was visualized by Coomassie blue staining.
5418 Nucleic Acids Research, 2005, Vol. 33, No. 17for bcTopo IIIa-catalyzed DNA relaxation is between 1 and
10 mM. In addition, bcTopo IIIa is able to tolerate concen-
trations of Mg
2+ up to 20 mM with only a slight decrease in
relaxation activity. High temperature inhibits the DNA relaxa-
tion activity of bcTopo I (Figure 4E). In contrast, high tem-
perature is needed for the optimal DNA relaxation activity of
bcTopo IIIa (Figure 4F). The optimal reaction temperature for
bcTopo IIIa-catalyzed DNA relaxation is 52 C, the same as
that of ecTopo III. Temperatures >37 C reduce the activity of
bcTopo I.
bcTopo I and bcTopo IIIa possess distinct
single-stranded DNA binding activity and exhibit
different DNA cleavage site specificity
To catalyze DNA relaxation, type IA topoisomerases need to
bind and transiently cleave single-stranded DNA present in
superhelical DNA molecules. Topoisomerase-mediated
single-stranded DNA mobility shift assays have been applied
to analyze the DNA binding activity of bcTopo I and bcTopo
IIIa (Figure 5A). A 28 base
32P-labeled oligonucleotide con-
taining ecTopo III cleavage sites was used as the substrate.
Although ecTopo I and bcTopo I possess three Zinc ﬁnger
motifs, bcTopo I does not have an extra C-terminal region
presentinecTopoI.ecTopoIandbcTopoIexhibitcomparable
single-stranded DNA binding activity. Furthermore, both
enzymes tend to form a protein–DNA supershift complex at
the high concentration of protein. This suggests that last
123 residues of ecTopo I C-terminal region may not be critical
for single-stranded DNA binding.
ecTopo III and bcTopo IIIa possess distinct C-terminal
regions and they exhibit different single–stranded DNA
binding activities. Having a putative zinc ﬁnger motif and a
highly charged C-terminal region, bcTopo IIIa bound to
single-stranded DNA is capable of forming a unique supershift
complex. The composition of this supershift complex is not
clear, multiple proteins may bind to a single DNA substrate
coordinately or individually, or a single protein may bind to
multiple oligonucleotides simultaneously.
The same radiolabeled 28 base oligonucleotides used in
DNA binding assay has also been used as a substrate to assess
the cleavage site speciﬁcity of bcTopo I, bcTopo IIIa,
ecTopo I and ecTopo III (Figure 5B). bcTopo I and ecTopo
I share three common cleavage sites but the enzymes prefer
differentsubsetsofthecleavage sites. bcTopoIIIaandecTopo
III also exhibit common cleavage sites with different prefer-
ences. bcTopo I and bcTopo IIIa do not share the same major
cleavage sites using this substrate. Besides supercoiled DNA
relaxation efﬁciency, the single-stranded DNA cleavage spe-
ciﬁcity may also be considered as another property that dis-
tinguishes ecTopo I-like topoisomerase from ecTopo III-like
enzymes.
Based on the X-ray crystal structure of ecTopo III (33),
residues from 165 to 195 should fold into a helix–turn–
helix structure and are part of the DNA binding cavity.
These residues may contribute to protein–DNA interactions.
Further sequence comparison of this fragment with other
ecTopo III-like enzymes reveals that residues of this region
are generally conserved (Figure 6). Interestingly, the corre-
sponding regions in ecTopo I-like enzymes are virtually
identical. Furthermore, several conserved residues present
in ecTopo III-like proteins are different from those present
in ecTopo I-like proteins. Therefore, this region may not only
be critical for DNA binding for type IA topoisomerases, but
may serve to delineate Topo-I like enzymes.
bcTopo IIIa is a potent DNA decatenase,
but not bcTopo I
ecTopo III is a potent decatenase that is capable of separating
multiple interlinked circular DNA dimers. A unique loop,
located near the large central cavity present in the enzyme,
has been shown to play an essential role in ecTopo III-
catalyzed DNA decatenation and termed as ‘decatenation
loop’ (9). Many ecTopo III-like enzymes also possess the
decatenation loop and exhibit DNA decatenation activity.
bcTopo IIIa also possesses the decatenation loop and it shares
similar biochemical properties with ecTopo III. bcTopo IIIa
Figure 3. (A) DNA relaxation assay of bcTopo I. Reactions (25 ml) contained
5m MM g
2+, 1 mM DTT, 30% glycerol, 100 ng/ml BSA and 40 mM Tris–HCl
(pH 8.0 at 22 C) with indicated amount of bcTopo I. Lanes 1–6: 312, 166, 88,
44, 22 and 0 fmol of bcTopo I, respectively. The reactions were incubated at
37 C for 30 min. The reaction products were eletrophoresed through a 1% 1·
TAE agarose gel and the DNA topoisomers were visualized by ethidium bro-
midestaining.(B)DNArelaxationassayofbcTopoIIIa.Lanes1–5:1.25,0.25,
0.05, 0.01 and 0 pmol of bcTopo IIIa, respectively. The reactions (containing
2.5 mM Mg
2+ and as described in Materials and Methods) were incubated at
52 C for 10 min and reaction products were separated and visualized as
described above.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5419Figure 4. (A) Effect of pH on bcTopo I-mediated DNA relaxation. Reactions (25 ml) contained 125 fmol of bcTopo I, 2.5 mM Mg
2+ and 40 mM Tris–HCl with the
indicatedpHvalue.Lane1,noprotein;lanes2–8:Tris–HCl,pHof6.5,7.5,8.0,8.8,9.3,9.8and10.4,respectively.(B) EffectofpHonbcTopoIIIa-mediatedDNA
relaxation.Reactions(25ml)contained125fmolofbcTopoIIIa,2.5mMMg
2+and40mMTris–HClwiththeindicatedpHvalue.Lane7,noprotein;lanes1–6:Tris–
HCl, pH of 7.5, 8.0, 8.8, 9.3, 9.8 and 10.4, respectively. (C) Effect of Mg
2+ concentration on bcTopo I-mediated DNA relaxation. Reactions were performed as
describedaboveexceptwithdifferentMg
2+concentrations.Lanes1–7:0,0.1,1,2.5,5,10and20mMMg
2+,respectively.Lane8,noprotein.(D) EffectofMg
2+on
bcTopo IIIa-mediated DNA relaxation. Lane 1, 1 mM of EDTA without Mg
2+; lanes 2–8, 0, 0.1, 1, 2.5, 5, 10 and 20 mM Mg
2+, respectively; Lane 9, no protein.
Reactions were performed as described above except with different Mg
2+ concentrations. (E) Effect of temperature on bcTopo I-mediated DNA relaxation.
Lanes 1–4, reactions were performed at 37, 42, 52 and 65 C, respectively; lane 5, no protein. Reactions were performed as described above except for different
incubation temperatures. (F) Effect of temperature on bcTopoIIIa-mediated DNA relaxation.Lane 1, no protein; lanes 2–5, reactionswere performedat 37, 42, 52
and 65 C, respectively. Reactions were performed as described above except for different incubation temperatures.
5420 Nucleic Acids Research, 2005, Vol. 33, No. 17Figure5. (A)Comparisonofthesingle-strandedDNAbindingactivitiesofbcTopoIIIb,ecTopoIII,bcTopoIandecTopoI.Theassaywasperformedasdescribedin
MaterialsandMethods.Reactions(10ml)contained5pmolof
32P-radiolabeledoligonucleotide,1mMMg
2+,1mMDTT,30%glycerol,100ng/mlBSAand40mM
Tris–HCl(pH8.0)andtheindicatedamountofprotein.Lane1,noprotein;lanes2–4:0.4,1.1and3.3pmolofecTopoIII;lanes5–7:0.4,1.1and3.3pmolofbcTopo
IIIa; lanes8–10:0.4,1.1 and3.3pmolofecTopoI; lanes11–13,0.4,1.1and3.3 pmolofbcTopoI.Thereactionswereeletrophoresedthrough12%polyacrylamide
gelin0.5·TBEandvisualizedbyautoradiography.(B)Comparisonofthesingle-strandedDNAcleavagesitespecificitiesofbcTopoIIIb,ecTopoIII,bcTopoIand
ecTopoI.TheassaywasperformedasdescribedinMaterialsandMethods.Reactions(10ml)contained5pmolof
32Pradiolabeledoligonucleotide,1mMMg
2+,1mM
DTT, 30% glycerol, 100 ng/ml BSA and 40 mM Tris–HCl (pH 8.0 at 22 C) and indicated amount of protein. Lane 1, no protein; lanes 2–4: 1.1, 3.3 and 10 pmol of
ecTopoIII,respectively;lanes5–7:1.1,3.3and10pmolofbcTopoIIIa,respectively;lanes8–10:1.1,3.3and10pmolofecTopoI,respectively;lanes11–13:1.1,3.3
and 10 pmol of bcTopo I, respectively. The reactions were electrophoresed through a 15% polyacrylamide gel in 1· TBE with 50% urea and visualized by
autoradiography. The common cleavage sites of bcTopo IIIa and ecTopo III are indicatedby right arrow; The common cleavage sites of bcTopo I and ecTopoI are
indicatedbyleftarrow;uniquecleavagesitescreatedbybcTopoIIIaareindicatedbydash;uniquecleavagesitescreatedbyecTopoIIIareindicatedbydottedarrow;
unique cleavage sites created by bcTopo I are indicated by dots.
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intermediates in vitro (Figure 7). Although bcTopo I is very
efﬁcient at the relaxation negatively supercoiled DNA, like
ecTopo I, it is not an efﬁcient decatenase. This implies that
different catalytic mechanisms have been applied by bcTopo I
and bcTopo IIIa to perform intramolecular (which results in
relaxation) and intermolecular (which results in decatenation)
strand passage.
bcTopo I and bcTopo IIIa are able to substitute for the
loss of ecTopo III in vivo
It has been proposed that ecTopo I in conjugation with DNA
gyrase regulates superhelical density in E.coli.Therefore, cells
with a deletion of topA (the gene encoding ecTopo I) can only
be isolated in the presence of a defective gyrase activity or
other compensatory mutations (6,7). Furthermore, it has been
shown that introducing a topB deletion to DM750 cells (a topA
deletion strain) is difﬁcult unless the cell harbors a topB
expression plasmid (28). Under these circumstances the tran-
scription and translation of the plasmid encoded topB gene
presumably provides enough ecTopo III protein for cells to
survive.
If bcTopo I and bcTopo IIIa can perform similar functions
as their E.coli counterparts in vivo, bcTopo IIIa should be able
to substitutefor the loss of ecTopoIII. To conﬁrm thisassump-
tion, P1 phage transduction has been used to introduce
a topB disruption into the DM750 chromosome. For this
study the genes encoding bcTopo I (pTopo1) and bcTopo
IIIa (pTopo3a) were subcloned into plasmid pET3c (resulting
in pBT1 and pBT3a, respectively). DM750 cells harboring
plasmids pDE1 (containing the E.coli topB gene in pET3c),
pTI1 (containing the E.coli topA gene in pET3c), pBT1 and
pBT3a were transduced to topB:kan
r by P1 phage. Consistent
with previous observations (28), cells containing pTI1 can not
be transduced to topB:kan
r; however, cells harboring either
pDE1, pBT3a and pBT1 can be transduced to topB:kan
r
(Table 1). The transduction efﬁciency of pBT3a containing
cells is increased  2-fold compared with that of pDE1 con-
taining cells, whereas the transduction efﬁciency of pBT1
containing cells is 3-fold reduced compared with that of
pDE1 containing cells.
DISCUSSION
B.anthracis, B.cereus and B.thuringiensis are closely related.
These organisms all have three chromosomally encoded type
IA topoisomerases. Moreover, bacteria such as C.pertringens,
C.tetani, E.faecalis and S.epidermidis also contain three chro-
mosome copies of type IA topoisomerases that exhibit exten-
sive amino acid sequence similarity with bcTopo I, bcTopo
IIIa and bcTopo IIIb, respectively (Table 2). In addition,
pXO1 and pXO2 plasmids, harbored by B.anthracis, may
encode two additional type IA topoisomerases. It has been
reported that pXO1 gene 142 encodes a type IA topoisomerase
termed TopX (34). Based on the published sequence, the
polypeptides derived from the pXO2 gene 77 and 76 show
sequence similarity with N- and C-terminal regions of a type
IA topoisomerase, respectively (35). If amber suppression
were to occur (an amber stop codon is present at the end of
gene 77), the ORF beginning at the gene 77 start codon would
continue through to the gene 76 stop codon and would encode
a complete type IA topoisomerase. Interestingly, this putative
topoisomerase shows 46% identity and 64% similarity with
hypothetical protein g of plasmid Streptococcus pyogenes
plasmid pDB101 (a type IA topoisomerase) (36) and also
exhibits 59% sequence similarity with bcTopo IIIa. It remains
to be determined whether the stop codon of gene 77 actually
exits (i.e. there may be a sequencing error) or whether
Figure 6. Sequencealignmentofa fragmentofDNAbindingregionconservedin typeIA topoisomerases.Proteinsequencecomparisonswereperformedusingthe
BlastP program (19). The same conserved residues present in both ecTopo I-like and ecTopo III-like proteins are indicated by plus; the residues that are conserved
in ecTopo I-like and ecTopo III-like proteins but are different between two groups are indicated by cross.
5422 Nucleic Acids Research, 2005, Vol. 33, No. 17translation can be accomplished through amber suppression.
In either case, some Bacillus species may have up to ﬁve type
IA topoisomerases. Other pXO2-like plasmids, such as
pAMb1, found in Gram-positive bacteria also possess an
active type IA TOP3. Clearly, it is important to understand
the redundancy and different functions of these enzymes.
Two of the B.cereus type IA topoisomerases have been
puriﬁed and characterized in this work. bcTopo I shares
extensive sequence similarity with ecTopo I (including three
C-terminal zinc ﬁnger motifs); however, its C-terminal region
is shorter (it lacks the last 123 amino acids at C-terminus of
ecTopo I) and it also lacks a highly positively charged
N-terminal loop (residues 41–69) present in ecTopo I. Since
bcTopo I and ecTopo I exhibit similar biochemical properties,
itappearsthattheseregions may notbecritical forthecatalytic
activity of bcTopo I but may relate to the speciﬁc biological
function of ecTopo I in vivo (e.g. by mediating protein–protein
interactions). bcTopo I is efﬁcient in relaxing negatively
supercoiled DNA in a processive manner. The DNA relaxation
activity of bcTopo I, similar to ecTopo I, is stimulated by high
concentration of Mg
2+ and is inhibited by high temperature. In
addition, bcTopo I and ecTopo I display comparable single-
stranded DNA binding activities and share common DNA
cleavage sites. Similar to ecTopo I, bcTopo I is not capable
of resolving multiple interlinked DNA dimers.
bcTopo IIIa and ecTopo III exhibit extensive protein
sequence homology within the ﬁrst 600 amino acids; however,
there is a little homology within their C-terminal sequence.
bcTopo IIIa has a highly charged C-terminal region including
a putative zinc ﬁnger motif. This may be involved in protein–
protein interactions to form hetero or homo protein com-
plexes. This would support the observation that bcTopo
IIIa tends to form a unique supershift complex with single-
stranded oligonucleotides when compared with ecTopo III. In
addition, bcTopo IIIa, unlike ecTopo III, is able to relax
supercoiled DNA under a broad range of Mg
2+ concentrations
ranging from a trace amount to 20 mM. Overall, however,
bcTopo IIIa is clearly an ecTopo III-like enzyme. Similar to
ecTopo III, it is inefﬁcient at the relaxation of negatively
supercoiled DNA and the activity is stimulated by high tem-
perature. bcTopo IIIa and ecTopo III also exhibit similar
single-stranded DNA cleavage speciﬁcity and more impor-
tantly, bcTopo IIIa is a potent decatenase, a characteristic
that is typical of ecTopo III-like enzyme.
According to amino acid sequence alignment of a protein
fragment that makes up a part of the DNA binding cavity
(ecTopo I, amino acid 164–199; ecTopo III, amino acid
162–201), ecTopo I-like enzymes have an almost identical
sequence when compared with ecTopo III-like enzymes
(that have relatively diverse sequences with conserved resi-
dues). This region may serve to distinguish ecTopo I-like
enzymes from other prokaryotic type IA topoisomerases.
Although bcTopo I and bcTopo IIIa exhibit distinctly dif-
ferent biochemical properties, they are both able to substitute
forthelossofecTopoIIIinE.coilDM750cells.Thisisdistinct
contrast to the results with ecTopo I. The inability of ecTopo I
to compensate for the loss of ecTopo III has been observed
previously (28). It is possible that this is a result of a perturba-
tion of chromosomal superhelical density owing to the pres-
ence of a gyrase compensatory mutation in DM750. This
mutation lowers gyrase activity in order to compensate for
Figure 7. Resolution of the oriC replication intermediates by bcTopo I and
bcTopo IIIa. The reactions (12.5 ml) contained no protein (lanes 1 and 6);
17.5 fmol of bcTopo I or bcTopo IIIa (lanes 2 and 6); 35 fmol of bcTopo I
or bcTopo IIIa (lanes 3 and 7); 70 fmol of bcTopo I or bcTopo IIIa (lanes 4
and 8); and 140 fmol of bcTopo I or bcTopo IIIa (lanes 5 and 10). The fully
decatenated form II molecules and late replication intermediate (LRI) are
indicated.
Table 1. P1 transduction frequencies of E.coli strain DM750 harboring
different plasmids
18 h incubation at 37 C Plasmid
None pDE1 pTI1 pBT3a pBT1
Transduction frequency (·10
 7) N/A 3.61 N/A 6.34 1.22
The data represents the average transduction frequency of three experiments.
The total numbers of transductants in three experiments were 477 (for strains
contain pDE1), 873 (for strain contain pBT3a) and 140 (for strain contain
pBT1). The topB:kan
r disruptions were confirmed by PCR amplification of
seven independent transductants from each group.
Table 2. Many Gram-positive bacteria possess multiple type IA
topoisomerases
Organism Gene Size amino
acid
Bits
score
References
E.coli K12 topB 653 1238 (5)
E.coli K12 topA 865 122 (4)
B.anthracis topBa 714 340 (20)
B.anthracis topBb 729 320 (20)
B.anthracis pXO2-77/76
a 676 289 (34)
B.anthracis pXO1-142
b 887 199 (32)
B.anthracis topA 692 105 (20)
B.cereus topBa 714 337 (21)
B.cereus topBb 729 328 (21)
B.cereus topA 692 107 (21)
C.tetani topBa 721 228 (24)
C.tetani topBb 730 323 (24)
C.tetani topA 696 115 (24)
E.faecalis topBa 705 315 (25)
E.faecalis topBb 693 262 (25)
E.faecalis topA 692 99 (25)
S.epidermidis topBa 718 249 (26)
S.epidermidis topBb 711 272 (26)
S.epidermidis topA 689 129 (26)
AminoacidssequencecomparisonofE.coliTopoIII(topB)inNCBImicrobial
genomic data base were done using BlastP program (19).
aA putativetopoisomerase encodedby pXO2plasmidwasformed by changing
the amber stop codon TAG of gene 77 to GAG.
bTopX encoded by pXO1 gene 142.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5423the loss of ecTopo I activity in the cell (6,7). Introduction of
the wild-type gene encoding ecTopo I into this strain could
lead to extensive relaxation of the host chromosome. We
believe that this explanation is unlikely, however. The speciﬁc
activity of bcTopo I and ecTopo I is very similar over a broad
range of pH and salt concentration (data not shown). It is quite
probable that both bcTopo I and ecTopo I would have the
same effect on overall intracellular supercoiling. The basis
for the observation may be rooted in protein–protein interac-
tions and the involvement of ecTopo I in a process other than
the maintenance of superhelical density (37).
Interestingly, similar to the results with ecTopoI, bcTopo
IIIb is also unable to compensate for the loss of Topo III in
DM750 (Z. Li and R. DiGate, manuscript submitted). This
indicates the inability of ecTopo I is not strictly unique to
this enzyme but has its basis in a true functional deﬁciency.
bcTopo IIIb is a unique topoisomerase that is different from
ecTopo I and III-like enzymes in that it only partially relaxes
supercoiled DNA and is not capable of resolving replication
intermediates during oriC DNA replication in vitro. Interest-
ingly, this enzyme is more closely related to topoisomerase III
encoded by bacteria such as B.subtilis (38), Bacillus licheni-
formis (39), Listeria monocytogenes (40), Oceanobacillus
iheyensis (41) and Staphylococcus aureus (42), and topoiso-
merase IIIb encoded by C.pertringens, Enterococcus facecalis
and S.epidermidis (these organisms encode two Topo III-like
proteins).
Prokaryotic type IA topoisomerases may have more diverse
functions than simply the maintenance of genomic stability (as
has been shown by eukaryotic type IA topoisomerases and
ecTopo III). These enzymes may have roles in the horizontal
gene transfer of promiscuous plasmids or conjugational trans-
posons. Type IA topoisomerases may also function in the
process of conjugational DNA transfer, transposon integration
(43), plasmid maintenance and plasmid segregation. To deal
with stringent environmental stressors such as UV, chemical
and free radical damage, bacteria may not only need sophis-
ticated DNA damage repair systems, but also efﬁcient DNA
recombinationsystems tocreate, adopt andspreadendogenous
or exogenous mutations. Therefore, different type IA topoi-
somerases may be required in a variety of DNA repair and
recombination processes. In addition, the characteristic cellu-
lar development stages such as sporulation and germination of
spore-forming Gram-positive bacteria may require DNA rep-
lication and recombination systems that are different from
those of E.coli. It is possible that type IA topoisomerases in
concert with different partners fulﬁll in vivo functions that
have not yet been identiﬁed in E.coli.
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